Evidence map›Paper›PMID 30901340›Full record

ArticlePLoS genetics2019

A synonymous germline variant in a gene encoding a cell adhesion molecule is associated with cutaneous mast cell tumour development in Labrador and Golden Retrievers.

Deborah Biasoli, Lara Compston-Garnett, Sally L Ricketts, Zeynep Birand, Celine Courtay-Cahen, Elena Fineberg, Maja Arendt, Kim Boerkamp, Malin Melin, Michele Koltookian and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Deborah BiasoliAnimal Health Trust, Newmarket, United Kingdom.ORCID 0000-0002-9161-4897
Lara Compston-GarnettAnimal Health Trust, Newmarket, United Kingdom.
Sally L RickettsAnimal Health Trust, Newmarket, United Kingdom.ORCID 0000-0002-5644-7958
Zeynep BirandAnimal Health Trust, Newmarket, United Kingdom.
Celine Courtay-CahenAnimal Health Trust, Newmarket, United Kingdom.
Elena FinebergAnimal Health Trust, Newmarket, United Kingdom.
Maja ArendtScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Kim BoerkampDepartment of Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands.
Malin MelinScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-6589-2375
Michele KoltookianBroad Institute of MIT and Harvard, Cambridge, MA, United States of America.
Sue MurphyAnimal Health Trust, Newmarket, United Kingdom.
Gerard RuttemanDepartment of Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands.
Kerstin Lindblad-TohScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Mike StarkeyAnimal Health Trust, Newmarket, United Kingdom.
Animal Health Trust · GBBroad Institute · USUppsala University · SEUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cell tumours are the most common type of skin cancer in dogs, representing a significant concern in canine health. The molecular pathogenesis is largely unknown, but breed-predisposition for mast cell tumour development suggests the involvement of inherited genetic risk factors in some breeds. In this study, we aimed to identify germline risk factors associated with the development of mast cell tumours in Labrador Retrievers, a breed with an elevated risk of mast cell tumour development. Using a methodological approach that combined a genome-wide association study, targeted next generation sequencing, and TaqMan genotyping, we identified a synonymous variant in the DSCAM gene on canine chromosome 31 that is associated with mast cell tumours in Labrador Retrievers. DSCAM encodes a cell-adhesion molecule. We showed that the variant has no effect on the DSCAM mRNA level but is associated with a significant reduction in the level of the DSCAM protein, suggesting that the variant affects the dynamics of DSCAM mRNA translation. Furthermore, we showed that the variant is also associated with mast cell tumours in Golden Retrievers, a breed that is closely related to Labrador Retrievers and that also has a predilection for mast cell tumour development. The variant is common in both Labradors and Golden Retrievers and consequently is likely to be a significant genetic contributor to the increased susceptibility of both breeds to develop mast cell tumours. The results presented here not only represent an important contribution to the understanding of mast cell tumour development in dogs, as they highlight the role of cell adhesion in mast cell tumour tumourigenesis, but they also emphasise the potential importance of the effects of synonymous variants in complex diseases such as cancer.

Indexed as

AnimalsCell AdhesionCell Adhesion MoleculesDog DiseasesDogsGenetic Predisposition to DiseaseGenome-Wide Association StudyGerm CellsGerm-Line MutationMast CellsMastocytoma, SkinMastocytosis, CutaneousRisk FactorsSilent MutationSkin NeoplasmsCell Adhesion Molecules

Identifiers

PMID30901340
PMCPMC6447235
OpenAlexW2923960365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.